Clin2
NCT06422975Likely a fitRecruiting

Shock treatment with vasopressin registry study

Vasopressin Causing Adverse Effects in Therapeutic UseShockVasopressor Adverse ReactionVasopressin Deficiency

Treatments studied

Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.

This study tracks people in shock who are treated with a drug called vasopressin in the operating room or intensive care unit. The goal is to see how well this treatment works in real-world situations.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years or older.
  • You are in shock (a life-threatening condition with low blood flow).
  • You need medications called vasoconstrictors to raise your blood pressure.
  • You will be treated with vasopressin in the operating room or intensive care unit.
  • You or your legal representative can give consent to take part in this study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06539234Recruiting
Testing angiotensin II for vasoplegic shock

This trial gives a drug called angiotensin II to people in vasoplegic shock (a type of shock where blood vessels stay too relaxed despite other medicines). It tests how the drug affects a kidney-related hormone (renin) and if it can help raise blood pressure.

Maribor
NCT07203833Recruiting
Vasorin test for shock diagnosis and outlook

This study looks at a protein called vasorin in the blood to see if it can help diagnose and predict outcomes in people with severe shock in the ICU. It compares patients with septic shock (caused by infection) to those with shock from other causes.

Amiens
NCT02118467Recruiting· Phase 4
Testing medicines that raise blood pressure in ICU shock patients

This trial studies whether “blood pressure–supporting” medicines (given through a central line) work well and safely for adults in the ICU who have shock. Your team may use the results to improve care for people with low blood pressure and poor blood flow to organs.

Chicago, Illinois
NCT06920173Recruiting· Phase 2
Low-dose vasopressors for shock in the ICU

This study tests whether giving low-dose blood pressure medicines through a standard IV (instead of a larger central line) is safe and effective for patients with shock in the intensive care unit.

Kingston, Ontario
NCT07052084Not yet recruiting· Phase 3
Testing added vasopressin for septic shock

This trial tests whether adding vasopressin (a drug that helps raise blood pressure) to standard treatment can help people with septic shock. It is for adults who already need a high dose of another blood pressure medicine called noradrenaline.

Marseille
NCT07697144Not yet recruiting
Adding vasopressin for septic shock in the ICU

This study tests whether adding a medicine called vasopressin helps improve blood pressure, urine output, and blood flow in patients with septic shock who are already in the ICU. If you are about to start vasopressin as part of your care, the study will see if it works better than other treatments alone.

Angers

Hear when a new Shock trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.